Life sciences and healthcare

Hogan Lovells International LLP

Hogan Lovells International LLP far-reaching practice encompasses expertise in areas including intellectual property, product liability and commercial litigation, regulatory and licensing. A trio of partners oversee matters: Stephen Bennett’s proficiency in contentious patent matters has made him a key contact for pharmaceutical companies. Matthew Felwick is well-placed to handle sensitive mandates such as coroners’ inquests following unexpected deaths. Jane Summerfield is frequently tasked with advising on the regulatory aspects of clinical trials, product authorisation and supply chain licensing. Further recommended are Penny Powell, who frequently guides clients through corporate and commercial deals in the life sciences, healthcare and technology sectors, and Stella Wong who excels in multi-jurisdictional patent litigation.

Legal 500 Editorial commentary

Key clients

Sandoz AG
Molecular Partners AG
Novartis AG
Adalvo Group
Eli Lilly (Lilly)
Bristol Myers Squibb (BMS)
Akebia Therapeutics
Astellas Pharmaceuticals
Viatris
Zimmer Biomet

Work highlights

Advised Molecular Partners AG on its research, development, manufacturing and commercialisation collaboration with Orano Med (a pioneer in targeted alpha therapy) to develop novel Radio-DARPin therapeutics (RDTs) that use Orano Med’s 212Pb radioisotope as a payload to selectively kill cancer cells.
Representing Astellas in litigation relating to its Betmiga product in the UK as part of its global litigation to maintain patent protection.
Acting for Zimmer Biomet and various European subsidiaries in relation to a voluntary recall, concerning Zimmer Biomet's NexGen Stemmed Option Tibial prosthetic knee component, and coordinating the defence of personal injury claims, including a threatened group action, across a number of European jurisdictions.